respiratory diseases

News

Trials set up filings for AZ's triple therapy in asthma

AstraZeneca's three-drug inhaler Breztri has shown efficacy for uncontrolled asthma in a pair of trials that could extend its label beyond COPD.

News

Sanofi's 'daughter of Dupixent' heads to phase 3 in asthma

Sanofi is preparing a phase 3 programme for asthma candidate amlitelimab, despite mixed data in a phase 2 trial.

News

Boehringer drug scores in another pulmonary fibrosis trial

Boehringer Ingelheim has a second positive trial under its belt for nerandomilast in pulmonary fibrosis, setting up regulatory filings.

News

Pliant slumps on decision to pause lung disease drug trial

Shares in Pliant plunged after the US biotech revealed that a safety signal led it to pause a trial of its idiopathic pulmonary fibrosis drug.

News

Roche launches 'revolutionary' pathogen detection tech

Roche has introduced the first test based on a new technology – called TAGS – that it believes could revolutionise testing for infectious diseases by allowing high-throughput detection to b

News

GSK says Nucala hits the target in new COPD trial

GSK's severe asthma therapy Nucala could find a new lease of life as a treatment for chronic obstructive pulmonary disease (COPD) after showing a clear benefit in a phase 3 trial.<

Trials set up filings for AZ's triple therapy in asthma

Sanofi's 'daughter of Dupixent' heads to phase 3 in asthma

Boehringer drug scores in another pulmonary fibrosis trial

Pliant slumps on decision to pause lung disease drug trial

Roche launches 'revolutionary' pathogen detection tech

GSK says Nucala hits the target in new COPD trial

FDA approves higher Wegovy dose via 4th priority voucher

Using AI-driven synthetic personas to take your insights fur...

respiratory diseases

Editor's Picks